Insider trade

Idexx Laboratories (IDXX): Officer sold ~$3.55M

Sharon E. Underberg, Officer at Idexx Laboratories, sold ~$3.55M of Idexx Laboratories shares.

~$3.55M
Approx. value · 5,450 sh @ $651.60
6,155.65
Holds after · shares reported
Traded
Aug 8, 2025
Filed
Aug 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 12, 2025CongressDisclosed sale of IDXX — reported range $100,001 - $250,000
  2. May 15, 2025CongressDisclosed purchase of IDXX — reported range $1,001 - $15,000
  3. Jul 9, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
  4. Aug 1, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
  5. Aug 6, 2025Insider · 3 peopleInsiders: 16 sales (~$28.3M)
  6. Aug 7, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
  7. Aug 8, 2025 · this disclosureInsiderOfficer sold ~$3.55M of IDXX shares in the open market

What came next

  1. Aug 11, 2025InsiderOfficer sold ~$788K of IDXX shares in the open market
  2. Aug 12, 2025Insider · 1 personInsiders: 2 sales (~$264K)
  3. Aug 22, 2025InsiderDirector sold ~$1.42M of IDXX shares in the open market
  4. Sep 4, 2025Congress · 1 personMembers of Congress: 2 purchases
  5. Oct 6, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective October 6, 2025, the board of directors (the “Board”) of IDEXX Laboratories, Inc. (the “Company”) elected Karen Peacock as an independent Class I Director and appointed her as a member of its Compensation and Talent Committee and Finance Committee.”
  6. Oct 16, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
  7. Oct 29, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
  8. Nov 3, 2025Company filing · Form 8-K · ResultsReported its results
  9. Nov 7, 2025Insider · 1 personInsiders: 4 sales (~$6.6M)
  10. Nov 12, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Idexx Laboratories

For Idexx Laboratories, OQRO holds 29 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IDXX page.

Other recent filings by Sharon E. Underberg, EVP, GC & Corporate Secretary

The full history of Sharon E. Underberg, EVP, GC & Corporate Secretary is on the profile page.

How this filing works

Explore the data

Common questions

Which Idexx Laboratories (IDXX) insider traded, and how much?

Sharon E. Underberg, Officer at Idexx Laboratories, sold ~$3.55M of Idexx Laboratories shares. 5,450 shares at $651.60.

When did it happen, and when was it made public?

Traded: Aug 8, 2025. Filed: Aug 12, 2025. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Idexx Laboratories recently?

For Idexx Laboratories, OQRO holds 29 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the IDXX page.

Does this mean IDXX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Idexx Laboratories

Everything OQRO holds on this company is on its IDXX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data